Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis

Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study)

(2016) Yuko Kaneko et al.   ANNALS OF THE RHEUMATIC DISEASES

Comparison of the clinical effectiveness of tumour necrosis factor inhibitors and abatacept after insufficient response to tocilizumab in patients with rheumatoid arthritis

(2016) Mitsuhiro Akiyama et al.   CLINICAL RHEUMATOLOGY

Association of disease activity with acute exacerbation of interstitial lung disease during tocilizumab treatment in patients with rheumatoid arthritis: a retrospective, case–control study

(2016) Mitsuhiro Akiyama et al.   RHEUMATOLOGY INTERNATIONAL

Predictive factors for induction of remission in patients with active rheumatoid arthritis treated with tocilizumab in clinical practice

(2016) Javier Narváez et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study

(2015) Cem Gabay et al.   ANNALS OF THE RHEUMATIC DISEASES

Comparison of tocilizumab and tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective analysis of 1603 patients managed in routine clinical practice

(2015) Marina Backhaus et al.   CLINICAL RHEUMATOLOGY

Patterns of use and dosing of tocilizumab in the treatment of patients with rheumatoid arthritis in routine clinical practice: the ACT-LIFE study

(2015) Alejandro Balsa et al.   RHEUMATOLOGY INTERNATIONAL

Comparative Effectiveness of Tocilizumab and TNF Inhibitors in Rheumatoid Arthritis Patients: Data from the Rheumatic Diseases Portuguese Register, Reuma.pt

(2015) Vasco C. Romão et al.   Biomed Research International

Clinical Utility of Random Anti-Tumor Necrosis Factor Drug-Level Testing and Measurement of Antidrug Antibodies on the Long-Term Treatment Response in Rheumatoid Arthritis

(2015) Meghna Jani et al.   Arthritis & Rheumatology

Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study

(2014) Maxime Dougados et al.   ANNALS OF THE RHEUMATIC DISEASES

Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study

(2014) T W J Huizinga et al.   ANNALS OF THE RHEUMATIC DISEASES

Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

(2014) Louise K Mercer et al.   ANNALS OF THE RHEUMATIC DISEASES

Tocilizumab is clinically, functionally, and radiographically effective and safe either with or without low-dose methotrexate in active rheumatoid arthritis patients with inadequate responses to DMARDs and/or TNF inhibitors: A single-center retrospective cohort study (KEIO-TCZ study) at week 52

(2014) Keisuke Izumi et al.   Modern Rheumatology

Importance of methotrexate therapy concomitant with tocilizumab treatment in achieving better clinical outcomes for rheumatoid arthritis patients with high disease activity: an observational cohort study

(2014) T. Kojima et al.   RHEUMATOLOGY

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

(2013) Josef S Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Monotherapy with tocilizumab or TNF-alpha inhibitors in patients with rheumatoid arthritis: efficacy, treatment satisfaction, and persistence in routine clinical practice

(2013) Jörg Kaufmann et al.   CLINICAL RHEUMATOLOGY

Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients with Rheumatoid Arthritis in Japan

(2013) T. Koike et al.   JOURNAL OF RHEUMATOLOGY

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

(2013) Cem Gabay et al.   LANCET

Pulmonary Disorders Induced by Monoclonal Antibodies in Patients with Rheumatologic Autoimmune Diseases

(2011) Manuel Ramos-Casals et al.   AMERICAN JOURNAL OF MEDICINE

Disease activity score 28 may overestimate the remission induction of rheumatoid arthritis patients treated with tocilizumab: comparison with the remission by the clinical disease activity index

(2011) Shin-ya Kawashiri et al.   Modern Rheumatology

An observational study of tocilizumab and TNF-  inhibitor use in a Japanese community hospital: different remission rates, similar drug survival and safety

(2011) K. Yoshida et al.   RHEUMATOLOGY

Integrated safety in tocilizumab clinical trials

(2011) Michael H Schiff et al.   ARTHRITIS RESEARCH & THERAPY

Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: The role of acute-phase reactants

(2010) Josef S. Smolen et al.   ARTHRITIS AND RHEUMATISM

BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies

(2010) T. Ding et al.   RHEUMATOLOGY

Efficacy of tocilizumab and evaluation of clinical remission as determined by CDAI and MMP-3 level

(2009) Keiko Funahashi et al.   Modern Rheumatology

Tumor Necrosis Factor Inhibitors and Lung Disease: A Paradox of Efficacy and Risk

(2009) Atul A. Khasnis et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Constructing Inverse Probability Weights for Marginal Structural Models

(2008) S. R. Cole et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY